ClinConnect ClinConnect Logo
Search / Trial NCT06879119

Clinical Evaluation of Localized Scalp Thread Embedding for Male Androgenetic Alopecia

Launched by BEIJING UNIVERSITY OF CHINESE MEDICINE, SHENZHEN HOSPITAL · Mar 11, 2025

Trial Information

Current as of April 29, 2025

Completed

Keywords

Androgenetic Alopecia Interventional Study Non Pharmacological Interventions

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Male sex
  • Age 18-50 years
  • No clinically significant comorbidities
  • Androgenetic alopecia (Hamilton-Norwood III-V)
  • No systemic anti-hair loss therapy use within 3 months
  • No topical hair regrowth agent use within 3 months
  • Exclusion Criteria:
  • Active scalp infection
  • Scalp psoriasis
  • Scalp eczema
  • Open scalp wounds
  • Allergy to thread materials
  • Uncontrolled diabetes mellitus
  • Immunodeficiency disorders
  • Non-compliance with follow-up visits
  • Refusal to provide informed consent
  • Investigator-deemed contraindications

About Beijing University Of Chinese Medicine, Shenzhen Hospital

Beijing University of Chinese Medicine, Shenzhen Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates traditional Chinese medicine with modern medical practices to explore novel therapeutic approaches. With a commitment to improving patient outcomes and contributing to global medical knowledge, the institution collaborates with multidisciplinary teams to conduct rigorous studies aimed at enhancing the understanding and treatment of various health conditions. Its state-of-the-art facilities and emphasis on patient-centered care position it as a vital contributor to the field of clinical research.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported